Cmv Clinical Trials 2022

Browse 40 Cmv Medical Studies Across 140 Cities

3 Phase 3 Trial · 298 Cmv Clinics

Reviewed by Michael Gill, B. Sc.
Photo of Toronto 1
Phase-Based Progress Estimates

Group 1: CMV - HFOVfor Ventilator-Induced Lung Injury

Toronto, Canada
Any Age
All Sexes
The use of positive end-expiratory pressure (PEEP) has been shown to prevent the cycling end-expiratory collapse during mechanical ventilation and to maintain alveolar recruitment, keeping lung portions open, increasing the resting end-expiratory volume. On the other hand PEEP may also overdistend the already open lung, increasing stress and strain. Theoretically high frequency oscillatory ventilation (HFOV) could be considered an ideal strategy in patients with ARDS for the small tidal volumes, but the expected benefits have not been shown yet. PEEP and HFOV should be tailored on individual physiology. Assuming that the esophageal pressure is a good estimation of pleural pressure, transpulmonary pressure can be estimated by the difference between airway pressure and esophageal pressure (PL= Paw - Pes). A PL of 0 cmH2O at end-expiration should keep the airways open (even if distal zones are not certainly recruited) and a PL of 15 cmH2O should produce an overall increase of lung recruitment. The investigators want to determine whether the prevention of atelectrauma by setting PEEP and mPaw to obtain 0 cmH2O of transpulmonary pressure at end expiratory volume is less injurious than lung recruitment limiting tidal overdistension by setting PEEP and mPaw at a threshold of 15 cmH2O of transpulmonary pressure. The comparison between conventional ventilation with tidal volume of 6 ml/Kg and HFOV enables us to understand the role of different tidal volumes on preventing atelectrauma and inducing lung recruitment. The use of non-invasive bedside techniques such as lung ultrasound, electrical impedance tomography, and transthoracic echocardiography are becoming necessary in ICU and may allow us to distinguish between lung recruitment and tidal overdistension at different PEEP/mPaw settings, in order to limit pulmonary and hemodynamic complications during CMV and HFOV.
Waitlist Available
Has No Placebo
25 Cmv Clinical Trials Near Me
Birmingham, AL
Los Angeles, CA
Boston, MA
Aurora, CO
More Trial Locations
An interactive map to display trial locations for Alabama CRS, UCLA CARE Center CRS, Massachusetts General Hospital CRS (MGH CRS), University of Colorado Hospital CRS, and 100 more locations.
Most Popular References for Cmv Clinical Trials
Top Cities for Cmv Clinical Trials
Phase 3 Cmv Clinical Trials
Clinical Trial
Began Recruiting Date
Senior Friendly Cmv Clinical Trials

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 30th, 2021

Last Reviewed: August 31st, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.